Preservation with 8-bromo-cyclic GMP improves pulmonary function after prolonged ischemia

Robert C. King, Victor E. Laubach, R. Chai Kanithanon, Adam M. Kron, Patrick E. Parrino, Kimberly S. Shockey, Curtis G. Tribble, Irving L. Kron

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Background. Cyclic guanosine monophosphate (cGMP) is a potent second messenger for the nitric oxide pathway in the pulmonary vasculature. Increased cytosolic cGMP levels elicit pulmonary vasodilatation resulting in decreased pulmonary vascular resistance and maximized pulmonary function after ischemia-reperfusion injury. We hypothesized that the addition of a membrane-permeable cGMP analogue (8-bromo-cGMP) to a Euro-Collins (EC) preservation solution would ameliorate pulmonary reperfusion injury better than prostaglandin E1 injection alone after prolonged hypothermic ischemia. Methods. All lungs from New Zealand White rabbits (weight, 3 to 3.5 kg) were harvested en bloc, flushed with EC solution, and reperfused with whole blood for 30 minutes. Group 1 lungs (immediate control) were immediately reperfused. Group 2 lungs (control) were stored inflated at 4°C for 18 hours before reperfusion. Groups 3 and 4 lungs were flushed with EC solution containing 200 μmol/L 8-bromo-cGMP and stored at 4°C for 18 and 30 hours, respectively. Fresh, nonrecirculated venous blood was used to determine single-pass pulmonary venous-arterial oxygen gradients at 10-minute intervals. Assays for cGMP, cyclic adenosine monophosphate, nitric oxide synthase activity, and myeloperoxidase were performed on all lung tissue samples. Wet to dry weight ratios were determined after 2 weeks of passive desiccation. Results. Oxygenation (venous-arterial oxygen gradient), pulmonary artery pressure, pulmonary vascular resistance, and edema formation were significantly improved in groups 3 and 4 (addition of 8-bromo-cGMP to EC plus 18 or 30 hours of hypothermic ischemia). Hypothermic storage (groups 2, 3, and 4) decreased both nitric oxide synthase activity and myeloperoxidase levels compared with immediate reperfusion (group 1). Conclusions. These results suggest that the addition of a membrane-permeable cGMP analogue to an EC pulmonary flush solution improves pulmonary function after prolonged storage compared with EC and prostaglandin (E1) preservation alone. The finding of myeloperoxidase reduced levels after hypothermic storage and subsequent reperfusion may suggest a more important role for pulmonary hemodynamic control in mitigating pulmonary reperfusion injury.

Original languageEnglish (US)
Pages (from-to)1732-1738
Number of pages7
JournalAnnals of Thoracic Surgery
Volume66
Issue number5
DOIs
StatePublished - Dec 1 1998
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Preservation with 8-bromo-cyclic GMP improves pulmonary function after prolonged ischemia'. Together they form a unique fingerprint.

  • Cite this

    King, R. C., Laubach, V. E., Chai Kanithanon, R., Kron, A. M., Parrino, P. E., Shockey, K. S., Tribble, C. G., & Kron, I. L. (1998). Preservation with 8-bromo-cyclic GMP improves pulmonary function after prolonged ischemia. Annals of Thoracic Surgery, 66(5), 1732-1738. https://doi.org/10.1016/S0003-4975(98)00991-6